Form 4 for KEQU KEWAUNEE SCIENTIFIC CORP /DE/
Accepted 2024-07-16 00:00:00 ET · period of report 2024-07-16 · accession 0001657070-24-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-07-16 | 2024-07-16 | KEQU | HULL THOMAS DAVID III | Pres, CEO, Dir | F - Tax | $52.00 | -7,877 | 46.5K | -14% | -$409.6K |
| DM | 2024-07-16 | 2024-07-16 | KEQU | HULL THOMAS DAVID III | Pres, CEO, Dir | M - OptEx | $20.13 | +12.0K | 48.4K | +33% | +$241.6K |
| DM | 2024-07-16 | 2024-07-16 | KEQU | HULL THOMAS DAVID III | Pres, CEO, Dir | M - OptEx | — | -12.0K | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-07-16 | F | D | 7,877 | $52.00 | 46,497 | D | — | — | (F1) Consideration for the exercise of the underlying option to buy was paid through a "net exercise" by directing the company to retain as payment for the total exercise cost a sufficient number of shares of Common Stock that would have been otherwise received upon exercise as reported below on this Form 4 report. (F2) Also includes shares withheld by the company to discharge withholding tax obligations of the reporting person. |
| 2 | Common | Common Stock | 2024-07-16 | M | A | 6,000 | $23.62 | 54,374 | D | — | — | (F1) Consideration for the exercise of the underlying option to buy was paid through a "net exercise" by directing the company to retain as payment for the total exercise cost a sufficient number of shares of Common Stock that would have been otherwise received upon exercise as reported below on this Form 4 report. |
| 3 | Common | Common Stock | 2024-07-16 | M | A | 6,000 | $16.64 | 48,374 | D | — | — | (F1) Consideration for the exercise of the underlying option to buy was paid through a "net exercise" by directing the company to retain as payment for the total exercise cost a sufficient number of shares of Common Stock that would have been otherwise received upon exercise as reported below on this Form 4 report. |
| 4 | Derivative | Option to Buy FY17 | 2024-07-16 | M | D | 6,000 | — | 0 | D | $23.62 · 2020-08-31 to 2026-08-31 | 6,000 Common Stock | (F3) Employee stock option granted under Employee Stock Option plan under Rule 16b-3. |
| 5 | Derivative | Option to Buy | 2024-07-16 | M | D | 6,000 | — | 0 | D | $16.64 · 2019-11-02 to 2025-11-02 | 6,000 Common Stock | (F3) Employee stock option granted under Employee Stock Option plan under Rule 16b-3. |